Publications by authors named "M Stoltenberg"
Palliative care (PC) is essential for improving the quality of life for individuals with serious illnesses, yet access to PC services remains limited, particularly in low- and middle-income countries (LMICs). This study aimed to assess the impact of a one-day PC training initiative for health care professionals in Uganda. Participants' pre- and post-course self-assessments, qualitative feedback, and satisfaction surveys were analyzed.
View Article and Find Full Text PDFContext: The COVID-19 pandemic presented unique challenges for health care systems. Overcrowded units, extreme illness severity, uncertain prognoses, and mistrust in providers resulted in a "pressure cooker" where traditional communication strategies were often insufficient.
Objectives: Building on well-studied traditional communication interventions, neurobiology principles were used to create a novel communication strategy designed in the COVID-ICU to respond to the unique communication needs of patients within the context of a high mistrust setting.
The development of an advanced diploma program for palliative care leaders in Chile.
Palliat Care Soc Pract
December 2023
Context: The majority of people with serious health-related suffering in low- and middle-income countries lack access to palliative care (PC). Increased access to PC education is greatly needed.
Objectives: This paper describes the process to adapt an advanced PC training course for a Chilean context.
Introduction: Qualitative and quantitative methods provide different and complementary insights into patients' preferences for treatment.
Objective: The aim of this study was to use a novel, mixed-methods approach employing qualitative and quantitative approaches to generate preliminary insights into patient preferences for the treatment of a rare disease-generalized myasthenia gravis (gMG).
Methods: We conducted a mixed-methods study to collect exploratory qualitative and quantitative patient preference information and generate informative results within a condensed timeline (about 4 months).
Article Synopsis
- The study analyzed the safety of intravenous lacosamide (LCM) in treating seizures in 686 children and 28 neonates over more than a decade.
- Adverse events linked to LCM were rare, occurring in only 1.5% of children, while no adverse events were reported in neonates, indicating a high safety profile.
- However, children receiving a higher-than-recommended initial dose faced a doubled risk of developing a rash, underlining the importance of adhering to dosage guidelines.